Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
07 déc. 2023 07h30 HE
|
Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
15 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla Biotech contracted with Filament Health to manufacture a second batch of MDMA capsules; manufacturing is complete and shipped to clients.
World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment
09 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla partners with Heroic Hearts Canada and the University of Calgary to launch the world's first observational rial into MDMA's real-world efficacy
Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy
08 nov. 2023 16h50 HE
|
Psychedelics Canada
PsyCan Endorses Senate Report into Psychedelic Treatments for Veterans
PharmAla Partners with Clariti Strategic Advisors™
08 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla signs long-term partnership with Clariti Strategic Partners as its investment banking and advisory firm
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
07 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer
07 nov. 2023 07h30 HE
|
Optimi Health Corp.
Optimi Health Introduces New Chief Science Officer Dr. Preston A. Chase.
Sunstone Therapies Announces Start of First Study of Multiple Doses of Psilocybin in Treatment of Depression in Patients with Cancer
06 nov. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Announces Start of First Study of Multiple Doses of Psilocybin in Treatment of Depression in Patients with Cancer Phase 2 study to examine safety and efficacy of up to two...
Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing
02 nov. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
Lucy Scientific Discovery’s Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
18 oct. 2023 07h00 HE
|
Lucy Scientific Discovery Inc.
From herbal remedies to psychedelics, like psilocybin and MDMA, Lucy Scientific is working to provide the ingredients for groundbreaking mental health ther